Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778
NCT02858271
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
AKB-9778 subcutaneous injection
Sponsor
Aerpio Therapeutics